AHA: Rivaroxaban May Cut Thromboembolic Risk in HF Patients Post hoc analysis of COMMANDER HF trial suggestive of benefit Nov 11, 2018 video
AHA: Zetia May Cut CV Events in Japanese Seniors Results from EWTOPIA75 trial not enough to change practice, experts says Nov 11, 2018
AHA: In-hospital Entresto Safe, Beneficial in HFrEF PIONEER-HF shows improved biomarkers and possibly outcomes too Nov 11, 2018 video
AHA: Fish Oil, Vitamin D Not VITAL to Heart Health VITAL trial also showed no benefits for cancer incidence with both supplements Nov 10, 2018 video
AHA: Targeting Inflammation With Methotrexate Flops for CV Prevention CIRT trial disappoints after CANTOS' win for the inflammatory hypothesis Nov 10, 2018 video
AHA: Prescription Fish Oil Wins for CV Prevention Positive findings for Vascepa in REDUCE-IT trial Nov 10, 2018 video
AHA: Revised Lipid Guide Boosts PCSK9s, Coronary Calcium Scans New recommendations aim to cut statins in low-risk primary prevention Nov 10, 2018 video
Heart Benefit with Dulaglutide; New Hot Flash Therapy; Diabetes Risks in Women News and commentary from the endocrinology world Nov 09, 2018
AHA: Lipid Guidelines to Headline Meeting Exercise, fish oil, Entresto in acute HF, and an anti-inflammatory also in the spotlight Nov 08, 2018
AHA: Late Meals Linked to HTN, Prediabetes Risks seen in study of Hispanic and Latino Americans Nov 06, 2018
Expert Panel: Cap Oxygen Saturation at 96% for Acutely Ill Patients Recommends special caution for stroke, MI patients Oct 25, 2018
Case Study: Influenza Turned Lethal Fulminant myocarditis claims life of otherwise healthy child Oct 22, 2018
Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilaris Health news and commentary from around the Web gathered by the ΑρΑ«ΚΣΖ΅ staff Oct 19, 2018
The Rest of the Story on Vitamin B for Stroke Prevention J. David Spence, MD, digs into the developing rationale for a different kind of B Oct 17, 2018
FDA Approves Rivaroxaban for CV Prevention in CAD, PAD Low dose to arrive in the U.S. next week Oct 12, 2018
NSAIDs OK for Certain High-Risk Groups? No obvious harm seen in HTN, HF, or chronic kidney disease Oct 08, 2018
Sandeep Jauhar's Real-Life Tales From, and of, the Heart Exploring the organ's intertwined metaphorical and biological aspects Oct 08, 2018
Withdrawn Diabetes Drug Worked in Secondary CV Prevention Large cardiovascular outcomes trial showed a particular reduction in MI Oct 05, 2018
Heart Benefit Seen with GLP-1 RA Albiglutide Significant reduction in myocardial infarctions; will drug be brought back to market? Oct 02, 2018
TCT: Near-Infrared Spectroscopy IDs Plaques Likely to Cause Problems Non-culprit lesions with large lipid core associated with events Sep 24, 2018
TCT: Stopping Antiplatelets 1 Year Post-Stent Risky for Afib Patients? Underpowered trial suggested oral anticoagulation alone isn't enough Sep 24, 2018
Vascepa Prevents Major Cardiovascular Events, Says Manufacturer Big win for proprietary fish-oil product Sep 24, 2018
TCT: Femoropopliteal Stents On Par in First Head-to-Head Trial Primary patency, major adverse events at least as good with Eluvia as Zilver PTX Sep 22, 2018
Macitentan Shows Promise in Portopulmonary Hypertension Positive results in first randomized trial in the disease Sep 20, 2018
Controlling BP Variability May Be Key to ICH Outcomes Aggressive BP reduction alone has failed in the past Sep 07, 2018
Aspirin, Fish Oil Disappoint in Primary CV Prevention Two randomized trials suggest little to no net benefit Aug 31, 2018
ESC: PURE Buries Controversy, Advocates for 'Balanced Diet' But dairy and red meat levels still differ from guidelines Aug 28, 2018
ESC: Interatrial Shunting Safe in HFpEF, Pivotal Trial to Come Device eases left-sided filling pressure, but to what clinical significance? Aug 27, 2018
ESC: Short DAPT with Ticagrelor Doesn't Improve Outcomes Antiplatelet strategy safe, but misses superiority to standard DAPT after stenting Aug 27, 2018 video
ESC: Aspirin Holds Little Net Benefit for Primary CV Prevention 'No compelling evidence' emerges in two randomized trials Aug 26, 2018 video
ESC: Omega-3 Supplements No Better Than Olive Oil for CV Risk 1-g dose disappoints in ASCEND trial Aug 26, 2018 video
ESC: Weight-Loss Drug Clears Major CV Hurdle Trial also shows modest reduction in new cases of diabetes Aug 26, 2018 video
ESC: Rivaroxaban Doesn't Prevent VTE after Acute Illness Efficacy shown in prior trial is lost, but safety gained in this setting Aug 26, 2018 video
Heart Health and Dementia Risk; The End of Pap Smears: It's PodMed Double T! This week's topics include dementia risk, the importance of serum cholesterol, Medicare's drug costs, and cervical cancer screening recommendations Aug 25, 2018 podcast
ESC: CTA for Stable Chest Pain Prevents More MIs Long Term Better than stress ECG as first-line test, SCOT-HEART investigators say Aug 25, 2018 video
Cath Lab Recap: Intracardiac Echo; Safe Late Lumen Loss Limit Interventional cardiology news to note Aug 23, 2018
NOAC's Brain Bleed Risk Outside Afib May Be Dose-Dependent Higher risk seen only with higher rivaroxaban doses in meta-analysis Aug 13, 2018
Don't Group Afib, Atrial Flutter Together in Evaluating Stroke Risk Same CHA2DS2-VASc score, different outcomes Aug 03, 2018